Knowledge Center

As a Leading Practice, the AHRMM Board of Directors adopts that Supply Chain Services be fully integrated into high cost clinical services departments.

This page provides information about submitting data to the database for device Labelers, entities responsible for providing the data to the GUDID.

How-to guide to managing IV disruptions. Download Tool

The Food and Drug Administration (FDA) UDI system is being phased in over several years. The first sunrise date (certain Class III devices) occurred 09/24/14. Recognizing UDI implementation will take time, healthcare supply chain and risk management professionals should be aware of already-implemented changes in the FDA’s adverse event reporting methodology. One of the changes required immediately is the use of the UDI in adverse event reporting.

To provide administrative support to the TCH IDS contracts process.

An overview of Fiscal Year (FY) 2015 Hospital Value-Based Purchasing (VBP) Program.

AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation between cost, quality, and outcomes.

Please see a sample of a Architect RFP below - you will find this short document covers all the basics, and you can tailor it to your needs.

Read examples of Green Light Projects illustrating how the performance improvement measures on the Sustainability Roadmap for Hospitals website can help your organization achieve sustainable design and operations.

Read how UPMC Health System is improving lives through redefined models of health care delivery, technological innovation and cutting-edge medical research.

In this page, AHRMM recommends these 3 proactive activities in the event of economic downturn.

In the fall of 2014, the University of Houston conducted a national study on hospital supply chain. With the support and participation from the AHRMM community, the University of Houston collected data from 266 hospitals and at least 60 percent of the respondents have an official designation of supply chain director or higher. Thank you to those who participated in the study. Your contribution is invaluable in helping academic institutions, AHRMM, and collaborating organizations better understand supply chain perspectives and best practices.  

AHRMM supports the concept and use of Comparative Effectiveness Research (CER) to provide evidence-based data to help inform purchasing decisions. CER is designed to support healthcare decisions by providing objective conclusions after comparing the effectiveness, benefits, and potential harm of various medical equipment, devices, or treatment options for specific episodes of care or states of disease.   By using objective data provided by CER, healthcare supply chain professionals have the ability to:

A sample of request for proposal for contractors to provide uniformed healthcare security services.

Review Supply Chain Analyst job description and tasks.

The FDA UDI ruling has finally arrived - the proposed rule has published. Please see the FDA website (www.fda.gov/udi) for a link to the proposed regulation. Highlights include a 120 day comment period to begin shortly, 6 months later a final ruling that will begin with Class III devices within 2 years, possibly sooner. Below is the FDA press release:

Hospital Compare: CMS Suspends Display of Hospital-Acquired Conditions Data

This document provides interim guidance for infection control for healthcare facilities (e.g., hospitals, long-term care and outpatient facilities, and other settings where healthcare is provided).

New Guidance on Humidity Levels in the Operating Room

Senior Contract Specialist job description.